Arthur Kuan, Chief Executive Officer of CG Oncology, Inc. (CGON), made a significant purchase of company stock on November 18, 2026. Kuan acquired 30,000 shares at a price of $78.88 per share, for a total investment of approximately $2.37 million.
This transaction represents a substantial capital commitment by a key executive. Insider purchases of this magnitude are often interpreted by the market as a signal of strong confidence in the company's future prospects and strategic direction.
The purchase by Kuan occurred on the same day as another insider buy, with Isabel Kalofonos purchasing 3,751 shares for approximately $300,000. In separate transactions earlier in November and October, Leonard E. Post sold a combined total of 2,000 shares.